Literature DB >> 18337230

Applications of laser scanning cytometry in immunohistochemistry and routine histopathology.

Richard A Peterson1, David L Krull, Leroy Butler.   

Abstract

Laser scanning cytometry (LSC) is a powerful tool for qualitative and quantitative analysis of tissue sections in preclinical drug development. LSC combines the strengths of flow cytometry with tissue architecture retention. This technology has been used predominantly with immunofluorescent techniques on cell culture and tissue sections, but recently LSC has shown promise in evaluating chromogenic immunohistochemistry (IHC) and histochemical products in paraffin-embedded and/or frozen tissue sections. Inverted light scatter measurements or a combination of inverted scatter and fluorescence allows automated determination of cell/nuclear counts (e.g., proliferation labeling indices), cell area (e.g., cellular hypertrophy), stromal elements, and labeling intensity (e.g., cytoplasmic/organellar proteins) in chromogen-labeled IHC or histochemical stained sections that correlates well with standard manual quantification methods. Segmentation with autofluorescence or dual immunolabeling facilitates capture of labeling data from specific cell populations. LSC evaluation of HE-stained sections is accomplished using autofluorescence/eosin fluorescence and inverse scatter. A standardized fluorescent approach with archivability, a lack of fluorescence quenching (photobleaching), and amenability to evaluation of multiple markers in a section has been demonstrated using Qdot nanocrystals. Examples of LSC use in chromogenic IHC, routine histopathology, and Qdot labeling will be reviewed, and advantages and disadvantages of this technology will be discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18337230     DOI: 10.1177/0192623307312704

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  8 in total

Review 1.  Laser scanning cytometry for automation of the micronucleus assay.

Authors:  Zbigniew Darzynkiewicz; Piotr Smolewski; Elena Holden; Ed Luther; Mel Henriksen; Maxime François; Wayne Leifert; Michael Fenech
Journal:  Mutagenesis       Date:  2011-01       Impact factor: 3.000

Review 2.  Laser scanning cytometry: principles and applications-an update.

Authors:  Piotr Pozarowski; Elena Holden; Zbigniew Darzynkiewicz
Journal:  Methods Mol Biol       Date:  2013

3.  Quantitative in situ analysis of FoxP3+ T regulatory cells on transplant tissue using laser scanning cytometry.

Authors:  Hidenori Takahashi; Phillip Ruiz; Camillo Ricordi; Victor Delacruz; Atsushi Miki; Atsuyoshi Mita; Ryosuke Misawa; Scott Barker; George W Burke; Andreas G Tzakis; Hirohito Ichii
Journal:  Cell Transplant       Date:  2011-09-16       Impact factor: 4.064

4.  Spatiotemporal effects of a controlled-release anti-inflammatory drug on the cellular dynamics of host response.

Authors:  Tram T Dang; Kaitlin M Bratlie; Said R Bogatyrev; Xiao Y Chen; Robert Langer; Daniel G Anderson
Journal:  Biomaterials       Date:  2011-03-23       Impact factor: 12.479

5.  Cell-based quantification of molecular biomarkers in histopathology specimens.

Authors:  Yousef Al-Kofahi; Wiem Lassoued; Kedar Grama; Sumit K Nath; Jianliang Zhu; Ridha Oueslati; Michael Feldman; William M F Lee; Badrinath Roysam
Journal:  Histopathology       Date:  2011-07       Impact factor: 5.087

6.  Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings.

Authors:  Robert A Ettlin; Junji Kuroda; Stephanie Plassmann; David E Prentice
Journal:  J Toxicol Pathol       Date:  2010-12-16       Impact factor: 1.628

7.  Ozanezumab dose selection for amyotrophic lateral sclerosis by pharmacokinetic-pharmacodynamic modelling of immunohistochemistry data from patient muscle biopsies.

Authors:  Alienor Berges; Jonathan Bullman; Stewart Bates; David Krull; Nicola Williams; Chao Chen
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

Review 8.  Aneuploidy: a common and early evidence-based biomarker for carcinogens and reproductive toxicants.

Authors:  Daniele Mandrioli; Fiorella Belpoggi; Ellen K Silbergeld; Melissa J Perry
Journal:  Environ Health       Date:  2016-10-12       Impact factor: 5.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.